statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	814
SG - Singapore	114
IT - Italia	97
CN - Cina	86
BR - Brasile	53
RU - Federazione Russa	39
SE - Svezia	38
HK - Hong Kong	30
VN - Vietnam	26
DE - Germania	23
GB - Regno Unito	20
IN - India	19
FI - Finlandia	18
FR - Francia	12
BE - Belgio	10
AU - Australia	9
AR - Argentina	8
ZA - Sudafrica	8
IE - Irlanda	7
CA - Canada	6
CZ - Repubblica Ceca	6
ID - Indonesia	6
IQ - Iraq	6
BD - Bangladesh	5
AT - Austria	4
CI - Costa d'Avorio	4
JP - Giappone	4
MX - Messico	4
NL - Olanda	4
TN - Tunisia	4
ET - Etiopia	3
SA - Arabia Saudita	3
TR - Turchia	3
VE - Venezuela	3
CH - Svizzera	2
CO - Colombia	2
EC - Ecuador	2
ES - Italia	2
MA - Marocco	2
PK - Pakistan	2
PL - Polonia	2
RS - Serbia	2
SC - Seychelles	2
UA - Ucraina	2
AL - Albania	1
AM - Armenia	1
AZ - Azerbaigian	1
CG - Congo	1
CL - Cile	1
CR - Costa Rica	1
DJ - Gibuti	1
DZ - Algeria	1
EE - Estonia	1
IR - Iran	1
JO - Giordania	1
KE - Kenya	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
MD - Moldavia	1
MY - Malesia	1
NI - Nicaragua	1
NP - Nepal	1
OM - Oman	1
PE - Perù	1
PH - Filippine	1
PT - Portogallo	1
TH - Thailandia	1
Totale	1.539

Nome	#
Markers of neurodevelopmental impairments in early-onset psychosis	182
Circulating anti-brain autoantibodies in schizophrenia and mood disorders	172
Differences in psychopathology and behavioral characteristics of patients affected by conversion motor disorder and organic dystonia	166
Traumatic experiences in childhood and adolescence: a meta-analysis of prospective studies assessing risk for psychosis	154
Personality disorders and somatization in functional and organic movement disorders	148
Managing the link and strengthening transition from child to adult mental health Care in Europe (MILESTONE): Background, rationale and methodology	148
Correlation of health-related quality of life in clinically stable outpatients with schizophrenia	145
Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents	144
Validation of the Transition Readiness and Appropriateness Measure (TRAM) for the Managing the Link and Strengthening Transition from Child to Adult Mental Healthcare in Europe (MILESTONE) study	133
demographic clinical, and service-use characteristics related to the clinician’s recommendation to transition from child to adult mental health services	129
Perceived impact of the COVID-19 pandemic on child and adolescent psychiatric services after 1 year (February/March 2021): ESCAP CovCAP survey	71
Totale	1.592

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	72	7	1	0	3	1	9	4	3	6	12	9	17
2022/2023	154	15	23	11	20	11	24	1	16	20	3	7	3
2023/2024	53	2	10	2	12	3	7	5	4	1	0	0	7
2024/2025	280	1	2	14	11	8	32	33	25	21	18	35	80
2025/2026	576	82	28	39	56	80	31	49	19	77	48	22	45
2026/2027	23	23	0	0	0	0	0	0	0	0	0	0	0
Totale													1.592